Rights and permissions
About this article
Cite this article
Colesevelam add-on therapy cost effective in T2DM. Pharmacoecon. Outcomes News 613, 6 (2010). https://doi.org/10.2165/00151234-201006130-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201006130-00014